HUTCHMED (China) Limited
HCM
$17.93
$1.569.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.77% | -7.15% | -8.44% | 9.16% | 34.44% |
| Total Other Revenue | -273.96% | -273.96% | -- | -121.10% | -121.10% |
| Total Revenue | -1.41% | -14.94% | -24.80% | -22.21% | -19.34% |
| Cost of Revenue | -16.68% | -17.50% | -18.28% | -4.28% | 12.09% |
| Gross Profit | 213.30% | 18.13% | -54.33% | -93.23% | -127.92% |
| SG&A Expenses | -21.18% | -18.08% | -15.22% | -8.60% | -1.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.00% | -16.47% | -17.78% | -16.15% | -14.58% |
| Operating Income | 83.69% | 38.10% | -337.85% | -103.32% | -21.67% |
| Income Before Tax | 1,525.07% | 752.77% | -57.04% | -90.72% | -75.57% |
| Income Tax Expenses | 1,346.26% | 713.82% | 59.50% | 6.14% | -29.98% |
| Earnings from Continuing Operations | 1,207.73% | 758.84% | -62.24% | -105.53% | -50.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -383.68% | -1,392.00% | -40.45% | 88.05% | 117.36% |
| Net Income | 1,212.42% | 758.04% | -62.56% | -105.94% | -42.64% |
| EBIT | 83.69% | 38.10% | -337.85% | -103.32% | -21.67% |
| EBITDA | 93.20% | 53.51% | -217.99% | -119.06% | -20.80% |
| EPS Basic | 1,202.83% | 741.43% | -62.98% | -106.18% | -40.34% |
| Normalized Basic EPS | 294.78% | 36.82% | -55.96% | -79.50% | -29.21% |
| EPS Diluted | 1,168.55% | 837.50% | -63.77% | -115.95% | 1.20% |
| Normalized Diluted EPS | 287.18% | 41.94% | -55.30% | -79.45% | -12.50% |
| Average Basic Shares Outstanding | 0.19% | 0.43% | 0.67% | 0.82% | 0.97% |
| Average Diluted Shares Outstanding | 1.20% | 1.37% | 1.53% | 1.14% | 0.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |